Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization277 mentions
- NVIDIAorganization265 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
Field Medical
organization2 mentionslast seen Sep 20, 2026
Clinical-stage medical technology company advancing pulsed field ablation solutions for complex cardiac arrhythmias.
Relationships 6
- Field MedicaldevelopsFieldForce PFA System99% confidence2 sources
- Field Medicaldevelopspulsed field ablation99% confidence2 sources
- Field MedicalemploysSteven Mickelsen99% confidence2 sources
- Field MedicalemploysMark A. Turco99% confidence2 sources
- Field MedicalapprovesFieldForce PFA System85% confidence1 source
- Field Medicalfunded byFDA Breakthrough Device Designation85% confidence1 source
Relationship
Field MedicalemploysMark A. Turco
99% confidence2 supporting mentions
Either name opens that entity’s relationships.
Sources 2
- newsPR NewswireSep 20, 2026JACC: Clinical Electrophysiology Publishes 12-Month Outcomes from Field Medical's First-in-Human Field PULSE Trial: 94.2% Per-Vein PVI Durability with Optimized Waveform
Mark A. Turco, M.D., president and chief executive officer of Field Medical
- newsPR NewswireSep 20, 2026JACC: Clinical Electrophysiology Publishes 12-Month Outcomes from Field Medical's First-in-Human Field PULSE Trial: 94.2% Per-Vein PVI Durability with Optimized Waveform
Mark A. Turco, M.D., president and chief executive officer of Field Medical